PMID: 11605172Oct 18, 2001Paper

Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia

Seminars in Hematology
G Atweh, D Loukopoulos

Abstract

A number of pharmacological agents are currently available for the induction of fetal hemoglobin (HbF) in patients with sickle cell disease and beta-thalassemia. Here we review the development of this new class of therapeutics and summarize the clinical trials that investigate their efficacy in patients with hemoglobin disorders. Hydroxyurea is the first of these drugs to be approved by the Food and Drug Administration for the treatment of sickle cell disease. Currently, the major focus is the development of safer agents and combinations of drugs that can increase HbF to levels high enough to prevent all complications of the disease. Progress in adapting the same strategy to the treatment of thalassemic disorders has been much slower. Although all the agents that are effective in sickle cell disease have similar HbF-inducing activity in beta-thalassemia, their use has rarely resulted in significant amelioration of the anemia. More research and more effective agents will be needed to make a significant impact on thalassemia. Nonetheless, success in this relatively young field has been very gratifying; before the end of this decade, clinically meaningful induction of HbF may become an achievable goal in most patients with hemoglo...Continue Reading

Citations

Apr 20, 2005·Annals of Hematology·Ashish DixitV P Choudhry
Nov 26, 2003·Blood Cells, Molecules & Diseases·Anne C RybickiRonald L Nagel
Oct 23, 2004·Best Practice & Research. Clinical Haematology·Michel SadelainIsabelle Rivière
Sep 21, 2002·Lancet·Elliott Vichinsky
Oct 29, 2008·Evidence-based Complementary and Alternative Medicine : ECAM·Nicoletta BianchiRoberto Gambari
Oct 29, 2008·Evidence-based Complementary and Alternative Medicine : ECAM·Antara BanerjeeAnisur Rahman Khuda-Bukhsh
Jul 14, 2001·Radiographics : a Review Publication of the Radiological Society of North America, Inc·G J LonerganS L Abbondanzo
Apr 7, 2009·Blood Cells, Molecules & Diseases·Hassana FathallahGeorge F Atweh
Jan 1, 2009·Environmental Toxicology and Pharmacology·Sharbel MalufLucia Silla
Dec 13, 2005·Annals of the New York Academy of Sciences·Hassana FathallahGeorge F Atweh
Dec 13, 2005·Annals of the New York Academy of Sciences·Michel SadelainIsabelle Riviere
Feb 28, 2003·European Journal of Haematology·Erich Vinicius de PaulaFernando Ferreira Costa
Jun 15, 2007·British Journal of Haematology·Caterina Borgna-Pignatti
Nov 30, 2006·British Journal of Haematology·Lynn Quek, Swee Lay Thein
Jan 22, 2011·British Journal of Haematology·Ali T TaherDavid J Weatherall
Oct 15, 2013·International Journal of Laboratory Hematology·E L T ShimautiC R Bonini-Domingos
Mar 13, 2014·British Journal of Haematology·Luisa RonzoniMaria Domenica Cappellini
Jan 21, 2012·Blood Cells, Molecules & Diseases·Angela RissoGuglielmo Antonutto
Oct 21, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Sorabh Sharma, Rajeev Taliyan
Apr 15, 2011·Blood·Idowu AkinsheyeMartin H Steinberg
Jul 15, 2005·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Nigel G Laing, Kristen J Nowak
Sep 16, 2005·The New England Journal of Medicine·Deborah Rund, Eliezer Rachmilewitz
Apr 11, 2018·Journal of Basic and Clinical Physiology and Pharmacology·Adam O AbdulkareemLawrence A Olatunji
Apr 18, 2020·Molecular Therapy. Methods & Clinical Development·Christian BrendelDavid A Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.